Title
Agreeing to join the additional national opioid settlements pursuant to the amended Minnesota Opioids State-Subdivision Memorandum of Agreement and authorizing City staff to execute all necessary documents, including Participation Form(s) and accompanying Release(s), to ensure the City's participation in additional national opioid settlements (including but not limited to the settlements with Purdue Pharma L.P. and the Sackler Family as well as the settlements with opioid manufacturers Alvogen, Amneal, Apotex, Hikma, Indivior, Mylan, Sun, and Zydus).
Body
WHEREAS, the State of Minnesota and numerous Minnesota cities and counties are engaged in nationwide civil litigation against opioid supply chain participants related to the opioid crisis; and
WHEREAS, in 2021, the State of Minnesota, the City of Saint Paul, and numerous other Minnesota cities and counties previously agreed to the Minnesota Opioids State-Subdivision Memorandum of Agreement (“State-Subdivision Agreement”), which governed distribution of opioid settlement funds from multistate agreements with pharmaceutical distributors, as well as opioid manufacturers; and
WHEREAS, the State-Subdivision Agreement prioritizes flexibility for how local governments may use opioid settlement funds for opioids abatement and remediation, and which provides for 75% of the settlement funds to be distributed directly to local governments and 25% of the settlement funds to be distributed directly to the State; and
WHEREAS, the Minnesota Attorney General has signed on to several additional multistate settlement agreements with manufacturers, distributors, as well as pharmacy companies; and
WHEREAS, representatives of Minnesota’s local governments and of the State of Minnesota through the Office of the Attorney General agreed that the distribution of funds pursuant to these additional multistate settlement agreements and any future settlement agreements should be governed by the State-Subdivision Agreement, a...
Click here for full text